Resveratrol and metformin have been shown to mimic some aspects of caloric restriction and exercise. However, it remains unknown if these molecules also slow age-related synaptic degeneration, as previously shown for caloric restriction and exercise. In this study, we examined the structural integrity of neuromuscular junctions (NMJs) in 2-year-old mice treated with resveratrol and metformin starting at 1 year of age. We found that resveratrol significantly slows aging of NMJs in the extensor digitorum longus muscle of 2-year-old mice. Resveratrol also preserved the morphology of muscle fibers in old mice. Although metformin slowed the rate of muscle fiber aging, it did not significantly affect aging of NMJs. Based on these findings, we sought to determine if resveratrol directly affects NMJs. For this, we examined postsynaptic sites, the NMJ region located on the muscle peripheral membrane, on cultured myotubes derived from C2C12 cells. We discovered that resveratrol increases the number of postsynaptic sites on myotubes exhibiting a youthful architecture, suggesting that resveratrol directly affects the NMJ. Altogether, we provide compelling evidence indicating that resveratrol slows aging of NMJs and muscle fibers.
With increasing age, synapses in the central and peripheral nervous system degenerate, compromising neurotransmission, and causing cellular atrophy (1) (2) (3) (4) (5) . These deleterious changes at synapses inevitably lead to cognitive and motor dysfunction (5) (6) (7) (8) . Much of the knowledge regarding the specific cellular changes at aging synapses comes from studying the neuromuscular junction (NMJ), the synaptic contact made by α-motor neurons and extrafusal muscle fibers (9) . Unlike synapses in the central nervous system, the NMJ is accessible and large enough to visualize its structural features using light microscopy.
It is well documented that the NMJ undergoes a number of deleterious structural changes that include fragmentation of the postsynaptic site and partial or full degeneration of innervating α-motor axon nerve endings with increasing age (10) . These deleterious structural changes at NMJs are followed by muscle atrophy, which contributes to the loss of mobility that occurs with increasing age (11, 12) . In recent years, we have learned that a caloric restricted (CR) diet and exercise, two anti-aging factors, can attenuate and even reverse age-related structural changes at NMJs (10) . These effects on NMJs have added additional impetus for discovering small molecules that mimic the anti-aging effects of caloric restriction and exercise.
A number of small molecules have been shown to mimic the effects of caloric restriction and exercise. Among these, resveratrol, metformin, rapamycin, and 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR) have been shown to provide health benefits and attenuate aging of rodents (13) (14) (15) (16) (17) (18) . In recent years, several studies have explored the possibility that these anti-aging small molecules slow the decline of cognitive and motor function by preserving the structural integrity of synapses. In middle-aged rats treated with resveratrol, pyramidal neurons in the prefrontal cortex and hippocampus contain more and longer spines, suggesting that resveratrol leads to the formation of new synapses (19) . In addition, resveratrol has been shown to speed the repair of injured and disease-affected synapses (20, 21) . There is also growing evidence that metformin, rapamycin, and AICAR may promote the repair of synapses during aging, diseases, and injury (13, (22) (23) (24) (25) (26) . Despite these findings, it remains unknown if the aforementioned anti-aging small molecules directly or indirectly affect synapses. This is a difficult question to address in the central nervous system because of the complexity of neural circuits and small size of synapses.
In this study, we examined the effect of resveratrol and metformin on NMJs in mice and postsynaptic sites that form on cultured myotubes. We discovered that a resveratrol-rich diet slows the accumulation of age-associated structural changes at NMJs in mice. Resveratrol also increased the number of postsynaptic sites exhibiting a youthful architecture formed on cultured myotubes. In contrast, metformin had no significant effect on aging NMJs in mice, and only moderately increased the number of postsynaptic sites with a youthful topology on myotubes.
Materials and Methods

Mice
Old (24 months) and young adult (3 months) C57BL/6J wild-type mice were bred at the National Institute on Aging. Mice were anesthetized using isoflurane and then perfused transcardially with 10 mL of 0.1 M phosphate-buffered saline (PBS), followed by 25 mL of ice-cold 4% paraformaldehyde in 0.1 M PBS (pH 7.4). Only male mice were analyzed in this study. All experiments were carried out under NIH guidelines and animal protocols approved by the Virginia Tech Institutional Animal Care and Use Committee.
Dietary Regimens
Mice were fed: (i) standard AIN-93G food pellets ad libitum for their entire life; (ii) a CR diet (AIN-93G pellets with 40% less fat calories) ad libitum (27) starting at 4 months of age; and (iii) AIN-93G food pellets containing resveratrol at 400 mg/kg (16) or AIN-93G food pellets containing metformin at 1,000 mg/kg (17) starting at 1 year of age. Mice were sacrificed at 2 years of age to examine NMJs and muscle fibers.
Immunohistochemistry
NMJs and muscle fibers were stained as previously described (10, 28) . Briefly, whole extensor digitorum longus (EDL) muscles were stained with an antibody against synaptotagmin-2 (Syt2; DSHB; ZNP-1; 1:250) to label the terminal of motor axons and with alexa-555-tagged α-bungarotoxin (fBTX; Thermo Fisher Scientific; B35451; 1:1,000) to label nicotinic acetylcholine receptors (nAChRs). To visualize muscle fibers, the tibialis anterior (TA) muscle was cut in half at the largest diameter and placed in 10 × 10 × 5 mm TissueTek Cryomolds with Tissue Freezing Medium (Triangle Biomedical Science, Inc.) to generate 16 μm cross-sections. Muscle sections were then incubated with alexa-488-conjugated wheat germ agglutinin (WGA) and DAPI (4′,6-diamidino-2-phenylindole: Sigma-Aldrich; 28718-90-3; 1:1,000) diluted in 0.1 M PBS for 2 hours. Following incubation, muscles were washed three times with 0.1 M PBS and mounted using Vectashield (Vector Laboratories, H-1000).
Analysis of NMJs and Muscle Fibers
Images to analyze NMJs and muscle fibers in mice were acquired using a Zeiss LSM 700 confocal microscope. Maximum intensity projections from confocal z-stacks were created with Zen Black (Zeiss). NMJs and muscle fibers were analyzed as previously described (10) . NMJs were deemed fragmented if they contained more than five AChR islands. To determine the innervation status of NMJs, we imaged and analyzed the most superficial NMJs in the EDL muscle. These NMJs were uniformly labeled with the antibody against Syt2. NMJs were deemed denervated if Syt2 was completely missing or only partially overlapped (5%-95%) with the postsynaptic region (AChR clusters). In all experiments, at least four male mice were examined per age and per group. At least 50 NMJs were examined per animal. Muscle fiber size was analyzed using ImageJ and represented as μm 2 .
C2C12 Cultures
C2C12 cells (29) were plated in 8-well chamber slides coated with Poly-L-ornithine in sterile water (3 µg/mL; Sigma-Aldrich; P2533) and laminin in Dulbecco's Modified Eagle Medium (DMEM; 10 µg/mL; Thermo Fisher Scientific; 23017015) at 100,000 cells per well. Twenty-four hours post seeding, culture media (high-glucose DMEM, 20% fetal bovine serum, 1× Glutamine, Pen strep, Fungizone) was replaced with fusion media (high-glucose DMEM, 10% horse serum, 1× Glutamine, Pen strep, Fungizone). Cells were incubated at 37°C and 5.0% CO 2 .
Treatment of C2C12-Derived Myotubes
Resveratrol (150 µM) and metformin (1 mM) were diluted in fusion media. Fusion media served as the control for each treatment. Resveratrol and metformin were added to 6 days old myotubes for 24 hours.
Induction of Postsynaptic Sites on C2C12-Derived Myotubes Using Neural-Agrin
The active region of neural-agrin (30) was purchased from R&D Systems (550-AG). Neural-agrin (0.031 ng/µL) was added 3 days post-fusion to induce clustering of AChRs on the peripheral membrane of myotubes. To test the activity of neural-agrin, AChR clusters were visualized and counted using light microscopy.
Staining for AChRs on C2C12-Derived Myotubes
Myotubes were fixed using 4% paraformaldehyde plus 4% sucrose diluted in PBS at room temperature for 30 minutes. AChR clusters were stained using fBTX (1:500) in PBS for 2 hours at room temperature or overnight at 4°C. The myotubes were then washed three times with PBS and mounted using Vectashield mounting medium.
Analysis of AChR Clusters in Myotubes
Images of AChR clusters and myotubes were taken using a laser scanning confocal microscope (Zeiss LSM 710) with 40× (1.3 NA) objective. Four images in the center of every well were taken to determine the type and number of AChR clusters, and the size of myotubes. Images were then analyzed using FIJI software to determine the average number of AChR clusters and width per myotube per image. Only AChR clusters (also referred as postsynaptic sites) equal to or larger than 4 µm in diameter were examined. The following criteria are used to categorize postsynaptic sites: (i) plaques are closed AChR clusters; (ii) rings refer to circular and perforated AChR clusters; (iii) half-rings are AChR clusters resembling a half-moon structure; (iv) matured sites are composed of two to four AChR clusters; and (v) fragmented sites are composed of five or more independent AChR clusters.
Analysis of Myotube Size
To determine myotube size, the diameter was measured at the widest region of each myotube and the average diameter size was compared between conditions.
Statistics
Significance between control and treatment groups was determined using unpaired t test. The Kolmogorov-Smirnov test was used to compare the distribution of muscle fibers' cross-sectional area (CSA) between groups. Data were expressed as the mean ± SE (standard error). p < .05 was considered statistically significant.
Results
Resveratrol, But Not Metformin, Mimics the Effects of CR on Aging NMJs in Mice
We began this study by asking if resveratrol and metformin affect aging of NMJs in male C57BL/6 mice. For this, NMJs were examined in 2-year-old mice fed food pellets containing resveratrol at 400 mg/kg or metformin at 0.1% w/w starting at 1 year of age. We used three different cohorts of mice as controls: (i) 2-year-old mice fed a regular diet for their entire life; (ii) 2-year-old mice fed a diet containing 40% less calories, a CR diet, starting at 4 months of age; and (iii) 3-month-old mice fed a regular diet. Because CR has been shown to attenuate NMJ aging, we used CR as a positive control for the resveratrol and metformin treatments. We assessed structural features of NMJs in the EDL muscle ( Figure 1A-D) . To visualize NMJs, the postsynaptic region located on the muscle fiber was labeled with fluorescently tagged α-bungarotoxin (fBTX), which binds with high affinity to nAChR. Motor nerve endings (the presynapse) innervating muscle fibers were stained with an antibody against Syt2, a protein associated with synaptic vesicles. Although we were able to readily visualize all presynaptic sites in the EDL muscle using anti-Syt2, presynaptic sites located within 60 µm of the muscle superficial surface were better labeled. We thus only analyzed NMJs located within 60 µm of the muscle surface.
We examined NMJs for fragmentation and denervation, two cellular features closely associated with aging NMJs in the EDL muscle (10) . Compared with mice fed a regular diet ( Figure 1B , E, and F), we found significantly fewer fragmented and denervated NMJs in aged mice fed a resveratrol-rich diet ( Figure 1D-F ). There were also significantly fewer degenerating NMJs in old mice fed a CR diet ( Figure 1C , E, and F), as previously shown (10). In (A-D) The architecture of NMJs was examined in the extensor digitorum longus (EDL) muscle of young adult mice (3M for 3-month-old) and old mice (24M for 24-month-old) fed a regular (Ctrl), a caloric restricted (CR) diet, resveratrol-rich (Resv), or metformin-rich diet (Met and see Supplementary Figure 1 for images of NMJs). Compared with old mice fed a regular diet, fewer fragmented (E) and denervated (F) NMJs were found in mice fed a CR diet and a resveratrol-rich diet. A metformin-rich diet did not significantly alter the incidence of fragmented and denervated NMJs in old mice (E and F). Four male C57BL/6 mice were examined per age and treatment. At least 50 NMJs were analyzed per mouse. Error bar = standard error. **p < .01; ***p < .001 versus old control. Scale bar = 10 µm.
contrast to resveratrol and CR, metformin had no discernable effect on aging NMJs ( Figure 1E and F) . Thus, resveratrol but not metformin (Supplementary Figure 1A and B) prevents the accumulation of age-related structural changes at NMJs in aging mice.
Reduced Muscle Fiber Size in Aged Mice Fed Resveratrol and on a CR Diet
Because a close relationship exists between the structural integrity of NMJs and muscle fibers, we asked if resveratrol also slows aging of muscle fibers in the TA muscle. We chose the TA muscle because of its similar function and muscle fiber composition to the EDL muscle. We examined the size of muscle fibers by staining 16 µm cross-sections of the TA muscle with fluorescently tagged wheat germ agglutinin (WGA) (Figure 2A and B) . Surprisingly, the mean muscle fiber CSA was similar between young adult and aged mice ( Figure 2C ). We also found no statistical differences in the mean muscle fiber CSA between mice fed resveratrol or metformin and old control mice ( Figure 2C ). However, muscle fibers were significantly smaller in old CR mice compared with old control mice (Figure 2A-C) .
With increasing age, the size of muscle fibers becomes more heterogeneous within a given muscle (31) . We therefore asked if the different dietary interventions affect the distribution of muscle fiber size in the TA muscle. For this, we generated a frequency histogram to visually inspect and compare the distribution of muscle fibers CSA across different treatments. This analysis revealed that the majority of muscle fibers were smaller in the TA muscle of old mice maintained in a CR and resveratrol diet compared with old control mice ( Figure 3A) . Both interventions reduced the number of large muscle fibers (1,750 µm 2 or larger), and increased the number of medium size fibers (500-1,250 µm 2 ), compared with young adult and old control mice ( Figure 3A) . To quantitatively compare the distribution of muscle fibers CSA between treatments, we performed a Kolmogorov-Smirnov test. Compared to old control mice, there are more muscle fibers with a smaller CSA in young adult and old mice fed a metformin, resveratrol, or CR diet ( Figure 3B ). Additionally, these data show that the distribution of muscle fibers CSA is similar between young adult and metformin-treated old mice ( Figure  3A and B) . This analysis also revealed that muscle fibers are significantly smaller in old mice fed a resveratrol-rich diet and a CR diet compared to muscle fibers in all other mice examined in this study ( Figure 3A and B ). These findings demonstrate that resveratrol, metformin, and a CR diet prevent the hypertrophy of muscle fibers that naturally occurs with increasing age.
Postsynaptic Sites in Cultured Myotubes Retain Their Youthful Topology in the Presence of Resveratrol
Since resveratrol was systemically administered, it is possible that NMJs are protected from aging by changes that occur elsewhere. To determine if resveratrol directly affects NMJs, we examined postsynaptic sites in myotubes (32) treated with resveratrol. The location and topology of postsynaptic sites were revealed by AChR clusters, which can be readily visualized using fBTX, located on the peripheral membrane of myotubes ( Figure 4A and B) . With increasing days in culture, AChR clusters, and thus postsynaptic sites, undergo a number of structural changes ( Figure 4D ) that appear as a: (i) small plaque; (ii) ring-like structure; (iii) half-ring-shaped structure; (iv) aggregation of two to four individual AChR clusters (herein referred to as matured clusters); and (v) aggregation of four or more individual AChR clusters (herein referred to as fragmented).
To determine the effect of resveratrol on AChR clusters, myotubes cultured for 7 days were treated with resveratrol for 24 hours. Resveratrol slowed the maturation but not the A and B) . The crosssectional area (CSA) was determined in muscle fibers from the tibialis anterior (TA) muscles of young adult mice (3M for 3-month-old) and old mice (24M for 24-month-old) fed a regular (Ctrl), a CR diet, resveratrol-rich (Resv), or metformin-rich (Met) diet (C). Error bar = standard error. *p < .05. Scale bar = 10 µm. number of AChR clusters ( Figure 4C and E) present on myotubes. Resveratrol-treated myotubes contained more AChR clusters exhibiting a plaque-like topology. Concomitantly, myotubes treated with resveratrol had fewer ring, half-ring, and matured AChR clusters. These findings suggest that resveratrol directly affects the NMJ.
In vivo, motor axons secrete agrin isoforms (neural-agrin) to stabilize postsynaptic sites (30, 33) . Through this function, neuralagrin increases the number of AChR clusters on cultured myotubes ( Figure 5A-C) . To determine if resveratrol synergizes with neuralagrin to maintain the structural integrity of NMJs, we examined the number of postsynaptic sites on myotubes treated with recombinant neural-agrin and resveratrol. We found that resveratrol failed to increase the number of postsynaptic sites formed by neural-agrin ( Figure 5D ). Because neural-agrin-derived postsynaptic clusters are small and maintain their plaque-shaped structure, we were unable to assess morphological changes caused by resveratrol treatments on neural-agrin-derived postsynaptic sites. Nevertheless, these findings suggest that resveratrol does not affect the number of NMJs but rather acts to influence the architecture of preexisting NMJs.
Resveratrol Increases the Size of Cultured Myotubes
In mice, resveratrol altered the morphology of muscle fibers in addition to the NMJ. We thus assessed the effect of resveratrol on the size of myotubes. We measured the width of 6 days old myotubes treated with resveratrol for the last 3 days in culture ( Figure 6A ). We found that resveratrol increased the size of myotubes in the absence and presence of neural-agrin ( Figure 6B and C) . These findings are in stark contrast to the effect of resveratrol on aging myofibers in vivo ( Figures 2C, 3A and B) . However, it is worth noting that myotubes fail to fully mature in culture unlike myofibers in fully developed mice. Thus, resveratrol may simply accelerate the development, and thus growth, of myotubes. Importantly, these cultured experiments revealed that the growth of myotubes and maturation of AChR clusters become dissociated in the presence of resveratrol.
Thus, resveratrol may recruit distinct molecular mechanisms to affect the size of muscle fibers and topology of the postsynaptic region of the NMJ.
Impact of Metformin on the Topology of Postsynaptic Sites and Size of Myotubes
Finally, we examined the impact of metformin on cultured myotubes. We assessed the topology of AChR clusters, postsynaptic sites, and width of 7 days old myotubes treated with metformin for the last 24 hours in culture. We found that metformin moderately decreased the total number of AChR clusters ( Figure 7A ), indicating that it metformin may halt the formation of new postsynaptic sites. Despite this effect, metformin increased the number of plaque-shaped postsynaptic AChR clusters compared with untreated myotubes ( Figure 7B ). Metformin also increased the number of ring-shaped postsynaptic AChR clusters ( Figure 7B ). Thus, metformin may also promote, albeit more moderately compared with resveratrol, the formation of youthful postsynaptic sites on myotubes.
We then asked if metformin affects the size of myotubes. In stark contrast to resveratrol (Figure 6 ), metformin had no effect on the size of myotubes ( Figure 7C ). Although these findings suggest that resveratrol and metformin differ in their effects on myotubes and postsynaptic sites, it is worth noting that older myotubes were used and treated for a shorter period of time with metformin. Thus, metformin may have a similar effect as resveratrol if added to myotubes earlier and for longer. The additional time in culture also likely explains the increased fragmentation of AChR clusters in the metformin experiment ( Figure 7B ) compared with the resveratrol experiment ( Figure 4E ). 
Discussion
The goal of this study was to determine the impact of two metabolic modulators and anti-aging small molecules, resveratrol and metformin, on synapses. Although these small molecules have been shown to slow the erosion of motor and cognitive function during aging (16, 17, 26, 34) , it remained unknown whether they directly affect synapses. We show that resveratrol slows aging of NMJs, the synapse formed between motor neurons and muscle fibers, in the EDL muscle. We also demonstrate that resveratrol induces the formation of postsynaptic sites exhibiting a "youthful" architecture in C2C12-derived myotubes. These findings suggest that resveratrol preserves motor function in part by protecting NMJs and muscle fibers. However, it is possible that resveratrol affects other cells that directly or indirectly impinge on the health of muscle fibers and NMJs, including motor neurons, Schwann cells, and satellite cells. These cells were not examined in this study.
Despite the protective effects of resveratrol on aging NMJs, we found it to be less effective compared with a CR diet in preventing agerelated changes at NMJs. However, mice were fed a 40% CR diet starting at 4 months of age, whereas resveratrol was introduced into the diet of 12-month-old mice. Thus, it is possible that introducing resveratrol earlier in life could be more efficacious at preserving the structural integrity of NMJs during aging. Unlike resveratrol, metformin did not slow age-related changes at NMJs. This finding is surprising given the benefits metformin has on mobility, health, and life span (17, 39, 43 ). Because we only tested one concentration of metformin, as well as resveratrol, it is possible that a different dose of metformin may slow aging of NMJs in mice. Supporting this possibility, we found that metformin applied directly to C2C12-derived myotubes induces the formation of postsynaptic sites with a "youthful" architecture. Future experiments may prove that the concentration of metformin used to treat myotubes in culture, and possibly other concentrations, slow aging of NMJs in vivo.
In addition, we show that resveratrol, metformin, and CR affect aging of muscle fibers in the TA muscle. In old mice fed a resveratrol-rich and a CR diet, there were fewer muscle fibers with a CSA of 1,750 µm 2 or larger. Instead, the number of medium size muscle fibers (500-1,250 µm 2 ) increased in aged mice. Metformin also increased the number of muscle fibers with a smaller CSA even though it did not affect the average mean CSA, similar to resveratrol. The shift in the distribution of muscle fiber size in animals treated with resveratrol and metformin indicates that some muscle fibers may be more responsive to these treatments. The TA muscle is composed primarily of fast fatigue-resistant (FFR) and fast fatigable (FF) muscle fibers. Because FF muscle fibers are larger and preferentially affected during aging (35), we hypothesize FF muscle fibers are more responsive to resveratrol, metformin, and a CR diet.
Interestingly, we found that CR significantly decreases the mean muscle fiber CSA in the TA muscle of 24-month-old mice. How can this finding be reconciled with prior studies showing that muscle mass is higher in old animals fed a CR diet compared with old control animals (36-38)? First, it is known that a CR diet prevents muscle fibers from atrophying in very old animals (38) . Thus, the higher number of muscle fibers likely accounts for the increased muscle mass in aged animals fed a CR diet rather than the size of individual fibers. This question could be fully answered in future experiments by counting the total number of muscle fibers in the TA muscle of mice fed a regular and a CR diet, in addition to determining the ratio of all the muscle fiber CSA to the TA muscle CSA.
The data presented in this paper indicate that resveratrol and metformin recruit signaling modules to maintain the structure of the NMJ as well as muscle fibers. The sirtuin and mTOR (The mechanistic target of rapamycin) pathways are prominent mechanistic candidates because they are present in skeletal muscles and known to be activated by resveratrol and metformin (34, (39) (40) (41) (42) (43) (44) . It is also important to note that CR modulates these pathways (45) . Thus, each small molecule and CR may affect aging of the NMJ by preferentially affecting specific branches of the sirtuin and mTOR pathways within skeletal muscles or specifically located at the pre-and postsynaptic regions of the NMJ. Alternatively, these interventions may recruit other molecular mechanisms that act directly on the NMJ. Supporting this possibility, we found that resveratrol slows the maturation of AChR clusters but increases the size of cultured myotubes. This finding is opposite of the normal developmental pattern observed in control myotubes and myofibers in vivo. In control myotubes and myofibers, there is a tight correlation between changes in the topology and size of AChR clusters and the size of myotubes or myofibers. The dissociation between changes in AChR clusters and size of myotubes suggest that resveratrol recruits molecular mechanisms that act both globally in muscle fibers and specifically on the postsynaptic region of the NMJ. The identification of such molecular pathways could lead to new approaches for preserving the NMJ and muscle fibers during aging.
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